期刊文献+

雷公藤多甙片联合半量激素治疗原发性膜性肾病30例 被引量:3

Treating 30 cases of membranous nephropathy by tripterygium wilfordii plus half amount of hormone
下载PDF
导出
摘要 目的:观察探讨雷公藤多甙片(Tripterygium Wilfordii,TW)联合半量激素(泼尼松)治疗原发性膜性肾病(Idiopathic Membranous Nephropathy,IMN)的临床疗效与安全性。方法:选取明确诊断为IMN的患者30例,给予TW(120mg/d)和泼尼松(30mg/d),并逐渐减量,同时给予补钙、调脂、抗血小板聚集等对症治疗,记录患者3个月、6个月、12个月的24h尿蛋白、血浆白蛋白(ALB)、血胆固醇(TC)、甘油三酯(TG)、谷丙转氨酶(ALT)、血肌酐(Scr)等相关生化指标,动态观察其临床疗效。结果:3个月时24h尿蛋白、TC、TG均有所下降,ALB有所提升,ALT、Scr基本无变化,6个月时各项指标较3个月时明显好转,12个月时各项指标均基本正常。结论:运用TW和半量激素(泼尼松)治疗IMN效果良好,患者耐受性较好,不良反应较少,是一种比较有效的治疗方法。 Objective: To observe and explore clinical efficacy and security of tripterygium wilfordii plus half amount of hormones(prednisone) in treating idiopathic membranous nephropathy. Methods: 30 patients diagnosed with IMN were given TW(120mg/d) plus prednisone(30mg/d),and slowly reducing the quantity, while giving calcium, lipid-lowering, anti-platelet aggregation and other symptomatic treatment, noted hydration therapy, recorded patients 3 months, 6 months,12 months' 24 h urinary protein, serum albumin(ALB), blood cholesterol(TC), triglycerides(TG), alanine transaminase(ALT), serum creatinine(Scr) and other biochemical markers while observing clinical efficacy dynamicly. Results: 3 months 24 h urinary protein?TC?TG were dropped,ALB were raised, ALT, Scr without changing, 6 months the indicators were significantly higher compared to 3 months, indicators of patients were basically normal in 12 months. Conclusion: TW plus half amount of hormone(prednisone) was effective in treating IMN, with better tolerance and seldom side effects,it was a more effective method of treatment.
出处 《中医临床研究》 2015年第20期10-12,共3页 Clinical Journal Of Chinese Medicine
关键词 膜性肾病 雷公藤 泼尼松 Idiopathic membranous nephropathy Tripterygium wilfordii Prednisone
  • 相关文献

参考文献2

二级参考文献6

  • 1鲍浩,章海涛,张馨,胡伟新,谢红浪,陈惠萍,曾彩虹,刘志红,黎磊石.难治性狼疮性肾炎多靶点治疗前瞻性临床研究[J].肾脏病与透析肾移植杂志,2007,16(1):5-13. 被引量:35
  • 2Du Buf-Vereijken PW, Branten A J, Wetzels JF. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy[J]. Am J Kidney Dis, 2005,46 (6): 1012-1029.
  • 3Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy[J]. N Engl J Med, 2009,361 ( 1 ): 11-21.
  • 4Waldman M, Austin HA 3rd. Controversies in the treatment of idiopathic membranous nephropathy[J]. Nat Rev Nephrol, 2009,5 ( 8 ) : 469-479.
  • 5Troyanov S, Roasio L, Pandes M, et al. Renal pathology in idiopathic membranous nephropathy : a new perspective[J]. Kidney Int, 2006,69 ( 9 ) : 1641-1648.
  • 6陈越,丁小强,钟一红,方艺,刘春凤,蒋素华.特发性膜性肾病合理治疗方案的研究[J].复旦学报(医学版),2009,36(6):741-745. 被引量:14

同被引文献26

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部